Caraco & Watson Digoxin / Propafenone Recall Lawsuit

Schmidt & Clark, LLP is No Longer Taking These Cases - If you feel that you may have a potential case, we urge you to contact another law firm adequately suited to handle your case.

Caraco Pharmaceutical Laboratories and Watson Pharmaceuticals has recalled some of their digoxin and propafenone tablets because of a variation in tablet size, which means that these products could contain more than the labeled amount of digoxin. Too much of the drug can cause digoxin toxicity and could lead to patient deaths.

June 25, 2009:U.S. Marshals Seize Drug Products Manufactured by Caraco Pharmaceutical Laboratories Ltd.

FDA Video: Recalls of Digoxin and Propafenone Tablets

Below is an excellent video published by the U.S. Food & Drug Administration (FDA), which warns patients and physicians of the digoxin propafenone recalls.

Link to Full Transcript: Recalls of Digoxin and Propafenone Tablets

Additional Information:

Awards & recognition